Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma-Reference-Cited by-同舟云学术

Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma

Published:2018-08-28 Issue:5 Volume:38 Page:475-483
ISSN:0919-6544
Container-title:Neuropathology
language:en
Short-container-title:Neuropathology

Author:

Leal Letícia F.¹,Evangelista Adriane F.¹,de Paula Flávia E.²,Caravina Almeida Gisele³,Carloni Adriana C.¹,Saggioro Fabiano⁴,Stavale João N.⁵,Malheiros Suzana M.F.⁵,Mançano Bruna⁶,de Oliveira Marco A.⁷,Luu Betty⁸,Neder Luciano¹³,Taylor Michael D.⁸,Reis Rui M.¹²⁹¹⁰^ORCID

Affiliation:

1. Molecular Oncology Research Center; Barretos Cancer Hospital; Barretos Brazil

2. Molecular Diagnostic Laboratory; Barretos Cancer Hospital; Barretos Brazil

3. Department of Pathology; Barretos Cancer Hospital; Barretos Brazil

4. Department of Pathology, Ribeirao Preto Medical School; University of São Paulo; Ribeirao Preto Brazil

5. Department of Pathology; Universidade Federal de São Paulo; São Paulo Brazil

6. Children and Young Adult's Cancer Hospital; Barretos Cancer Hospital; Barretos Brazil

7. Statistics Unity; Barretos Cancer Hospital; Barretos Brazil

8. Hospital for Sick Children; University of Toronto; Toronto Ontario Canada

9. Life and Health Sciences Research Institute (ICVS), Health Sciences School; University of Minho; Braga Portugal

10. ICVS/3B's-PT Government Associate Laboratory; Braga/Guimarães Portugal

Funder

Barretos Cancer Hospital

Financiadora de Estudos e Projetos

Public Ministry of Labor Campinas (Research, Prevention and Education of Occupational Cancer)

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Neurology (clinical),General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/neup.12508/fullpdf

Reference38 articles.

1. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: A SEER update. Surveillance epidemiology and end results;McNeil;Med Pediatr Oncol,2002

2. Management of and prognosis with medulloblastoma: Therapy at a crossroads;Packer;Arch Neurol,2008

3. INCA Instituto Nacional do Câncer - Estimativa 2010: Incidência de câncer no Brasil 2009 http://www2.inca.gov.br/wps/wcm/connect/agencianoticias/site/home/noticias/2009/lancamento_estimativa_2010

4. Adult medulloblastoma: Prognostic factors and patterns of relapse;Chan;Neurosurgery,2000

5. Childhood medulloblastoma: Novel approaches to the classification of a heterogeneous disease;Ellison;Acta Neuropathol,2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis;Cancer Cell International;2023-10-31

2. High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population;Frontiers in Oncology;2023-09-04

3. Affordable panel of techniques for prediction of molecular classification of a series of medulloblastomas in a reference pediatric hospital in Colombia;2023-03-02

4. Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets;Frontiers in Immunology;2023-02-07

5. Molecular subgrouping of medulloblastoma in pediatric population using the NanoString assay and comparison with immunohistochemistry methods;BMC Cancer;2022-11-28